Graham Capital Management L.P. Acquires New Position in Fate Therapeutics, Inc. (NASDAQ:FATE)

Graham Capital Management L.P. acquired a new stake in Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 142,401 shares of the biopharmaceutical company’s stock, valued at approximately $678,000. Graham Capital Management L.P. owned […]

Related Keywords

United States ,America , ,America Corp ,Millennium Management ,Securities Exchange Commission ,Blackrock Inc ,Wells Fargo Company ,Fate Therapeutics Inc ,Nasdaq ,Fate Therapeutics ,Free Report ,Street Corp ,Get Free Report ,Truist Financial ,Fate Therapeutics Daily ,Nasdaq Fate ,Fate ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,